Ethyl Glucuronide in Urine Samples of Pregnant Women Within the HUS ja PHHYKY Area
- Conditions
- Fetal Alcohol Spectrum Disorders
- Registration Number
- NCT04571463
- Lead Sponsor
- Hanna Kahila
- Brief Summary
In order to find how many women continue using alcohol during their pregnancies the plan is to anonymously test routine urine samples collected during pregnancies for ethylglucuronide (ETG), a metabolite of ethanol that is detectable in urine up to several days after alcohol consumptions. Altogether 600 samples are taken in the prenatal care units and the prenatal care units dedicated for the alcohol and drug abusing mothers both in the Helsinki and Lahti areas. Test results are used to estimate and compare the prevalence of severe maternal drinking in the different populations.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 505
- Pregnant
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method EtG Day 1 The routine urine samples from the visitors are tested for ethyl glucuronide using dip sticks with 300ng cut off. Positve finds are confirmed in a laboratory.
- Secondary Outcome Measures
Name Time Method Cannabis Day 1 The positive EtG urine samples and random negative urine samples from the visitors are tested for cannabis using dip sticks.
Nicotine Day 1 The positive EtG urine samples and random negative urine samples from the visitors are tested for nicotine using dip sticks.
Trial Locations
- Locations (3)
HALSO-poliklinikka
🇫🇮Lahti, Päijät-Häme, Finland
Äitiyspoliklinikka/neuvola
🇫🇮Helsinki, Uusimaa, Finland
HAL-poliklinikka
🇫🇮Helsinki, Uusimaa, Finland